|
|
|
|
| LEADER |
00000cam a22000008i 4500 |
| 001 |
KNOVEL_on1035811353 |
| 003 |
OCoLC |
| 005 |
20231027140348.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
180514s2018 mdu ob 000 0 eng |
| 010 |
|
|
|a 2018023481
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d OCLCO
|d OCLCQ
|d OCLCA
|d COO
|d OCLCO
|d OCLCA
|d UAB
|d OCLCO
|d KNOVL
|d YDX
|d CEF
|d OCLCO
|d STF
|d MERER
|d OCLCF
|d EBLCP
|d OCLCO
|d OCLCQ
|d N$T
|d ZCU
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d HNC
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781944888053
|q (electronic bk.)
|
| 020 |
|
|
|a 1944888055
|q (electronic bk.)
|
| 020 |
|
|
|z 9781944888046
|q (hardcopy)
|
| 029 |
1 |
|
|a AU@
|b 000062282108
|
| 035 |
|
|
|a (OCoLC)1035811353
|
| 042 |
|
|
|a pcc
|
| 050 |
1 |
0 |
|a RC270.3.R33
|b E93 2018
|
| 060 |
|
4 |
|a QZ 202
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.99/40757
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Evaluation of the relative effectiveness of low-energy photons and electrons in inducing cancer in humans.
|
| 263 |
|
|
|a 1805
|
| 264 |
|
1 |
|a Bethesda, Maryland :
|b National Council on Radiation Protection and Measurements,
|c May 2018.
|
| 300 |
|
|
|a 1 online resource (x, 280 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a NCRP report ;
|v no. 181
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher; resource not viewed.
|
| 505 |
0 |
|
|a Cover; Preface; Contents; 1. Executive Summary; 2. Introduction; 2.1 Background for Present Study; 2.1.1 Recommendations for Purposes of Radiation Protection; 2.1.2 Assumptions for Purposes of Cancer Risk Assessment; 2.1.3 Previous Reviews by NCRP; 2.2 Importance of Present Evaluation; 2.3 Term to Describe Modifying Factor to Represent Biological Effectiveness; 2.4 Specification of Reference Radiation; 2.5 Use of Effectiveness Ratio in Cancer Risk Assessments; 2.6 Approach to Evaluation of Biological Effectiveness
|
| 505 |
8 |
|
|a 3. Spectral Characteristics of Representative Low Linear-Energy Transfer Radiations3.1 Production of Energetic Secondary Electrons by Photons; 3.2 Representative Spectra of Incident Photons; 3.3 Spectra of First-Collision Electrons and Tritium Beta Particles; 3.4 Spectra of Lower-Energy Electrons Produced by First-Collision Electrons; 4. Line of Evidence: Microdosimetry; 4.1 Lineal-Energy Distributions Produced by Photons; 4.2 Prediction of Ri Based on f(y); 4.3 Evaluation of the PDF of Ri; 5. Line of Evidence: Deoxyribonucleic Acid Damage; 5.1 DNA Damage from Ionizing Radiation
|
| 505 |
8 |
|
|a 5.2 Photon and Electron Damage to DNA5.3 Experimental Data on Relative Biological Effectiveness for DNA Double-Strand Breaks; 5.4 Relative Biological Effectiveness of DNA Double-Strand Breaks from Theoretical Simulations; 5.5 Enhancement of Relative Biological Effectiveness for Slow-Rejoining Double-Strand Breaks; 5.6 Enhancement of Relative Biological Effectiveness for Complex Double-Strand Breaks from Simulations; 5.7 Role of DNA Base Damage; 5.8 Estimation of Probability Density Functions for Ri of Double-Strand Breaks and also with Enhancement for Biological Severity
|
| 505 |
8 |
|
|a 5.8.1 PDFs of Ri for 15 to 30 keV Photons5.8.2 PDFs of Ri for 1.5 keV Photons; 5.8.3 PDF of Ri for 40 to 60 keV Photons; 5.8.4 PDF of Ri for>60 to 150 keV Photons; 5.8.5 PDF of Ri for Tritium Beta Particles; 5.8.6 Summary of Recommended PDFs; 5.8.7 Relevance of Ri for Initial DSBs in DNA; 6. Line of Evidence: Cellular Radiobiology and Animal Studies; 6.1 Introduction; 6.2 Structural Chromosome Aberrations; 6.2.1 Studies Using Conventional Giemsa Staining; 6.2.2 Difficulties with Studies Using Giemsa Staining; 6.2.3 Studies Using FISH and mFISH; 6.3 Micronuclei
|
| 505 |
8 |
|
|a 6.4 Cell Survival and Cell Killing6.5 Cell Mutation; 6.6 Cellular Transformation; 6.7 Effects in Cells (in vitro and in vivo) from Low-Energy Radionuclide Emissions; 6.8 Other Considerations of Cellular Effects; 6.9 Studies of Cancer and Other Organ Endpoints in Whole Animals; 6.9.1 Studies with External Radiation; 6.9.2 Studies with Radionuclides Incorporated in Animal Tissues; 6.10 Development of Probability Density Functions of Ri; 6.10.1 Photons of Energy 1.5 keV (AlK); 6.10.2 Photons of Energy 15 to 30 keV; 6.10.3 Photons of Energy 40 to 60 keV or>60 to 150 keV
|
| 590 |
|
|
|a Knovel
|b ACADEMIC - Safety & Industrial Hygiene
|
| 650 |
|
0 |
|a Cancer
|x Radioimmunotherapy.
|
| 650 |
1 |
2 |
|a Neoplasms, Radiation-Induced
|x etiology
|
| 650 |
1 |
2 |
|a Radiation Exposure
|x adverse effects
|
| 650 |
2 |
2 |
|a Linear Energy Transfer
|x radiation effects
|
| 650 |
|
6 |
|a Cancer
|x Radioimmunothérapie.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cancer
|x Radioimmunotherapy
|2 fast
|
| 710 |
2 |
|
|a National Council on Radiation Protection and Measurements,
|e issuing body.
|
| 776 |
0 |
8 |
|i Print version:
|t Evaluation of the relative effectiveness of low-energy photons and electrons in inducing cancer in humans.
|d Bethesda, Maryland : National Council on Radiation Protection and Measurements, May 2018
|z 9781944888046
|w (DLC) 2018019328
|
| 856 |
4 |
0 |
|u https://appknovel.uam.elogim.com/kn/resources/kpNCRPRN01/toc
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5720794
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2035379
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 16080082
|
| 994 |
|
|
|a 92
|b IZTAP
|
